Works by Wu, Wenting

Results: 189
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Genome-wide association study in 176,678 Europeans reveals genetic loci for tanning response to sun exposure.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04086-y
    By:
    • Visconti, Alessia;
    • Duffy, David L.;
    • Fan Liu;
    • Gu Zhu;
    • Wenting Wu;
    • Yan Chen;
    • Hysi, Pirro G.;
    • Changqing Zeng;
    • Sanna, Marianna;
    • Iles, Mark M.;
    • Kanetsky, Peter A.;
    • Demenais, Florence;
    • Hamer, Merel A.;
    • Uitterlinden, Andre G.;
    • Ikram, M. Arfan;
    • Nijsten, Tamar;
    • Martin, Nicholas G.;
    • Kayser, Manfred;
    • Spector, Tim D.;
    • Jiali Han
    Publication type:
    Article
    33

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Overexpression of IL-17RC associated with ocular sarcoidosis.

    Published in:
    Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-152
    By:
    • Wenting Wu;
    • Ming Jin;
    • Yujuan Wang;
    • Baoying Liu;
    • Defen Shen;
    • Ping Chen;
    • Hannes, Susan;
    • Zhiyu Li;
    • Hirani, Sima;
    • Jawad, Shayma;
    • Sen, H. Nida;
    • Chi-Chao Chan;
    • Nussenblatt, Robert B.;
    • Lai Wei
    Publication type:
    Article
    46
    47
    48
    49

    Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 7, p. 757, doi. 10.1002/ajh.23737
    By:
    • Zent, Clive S.;
    • Taylor, Ronald P.;
    • Lindorfer, Margaret A.;
    • Beum, Paul V.;
    • LaPlant, Betsy;
    • Wu, Wenting;
    • Call, Timothy G.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Frederick, Lori A.;
    • Link, Brian K.;
    • Blackwell, Sue E.;
    • Veeramani, Suresh;
    • Baig, Nisar A.;
    • Viswanatha, David S.;
    • Weiner, George J.;
    • Witzig, Thomas E.
    Publication type:
    Article
    50